Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Antiviral Res. 2014 Jul 19;110:10–19. doi: 10.1016/j.antiviral.2014.07.007

Table 3.

Maximum L-BHDU concentration two hours post final treatment

Tissue 150 mg/kg/day (n = 5) 8 mg/kg/day (n = 4)
Max. Conc. Ratio to Plasma Max. Conc. Ratio to Plasma
Plasma 13.9 (3.9)a 1 0.3 (0.2) 1
Brain 1.1 (0.3)b 0.1 (0.03) 0.1 (0.02) 0.4 (0.3)
Skin (Human) 11.3 (1.1)b 0.9 (0.3) 0.7 (0.1) 3.1 (2.6)
Skin (Mouse) 11.8 (1.0)b 0.9 (0.2) 0.7 (0.1) 3.0 (2.5)
Heart 13.7 (2.8)b 1.0 (0.2) 0.7 (0.1) 2.9 (2.5)
Spleen 18.8 (6.2)b 1.4 (0.2) 0.6 (0.2) 2.1 (1.3)
Liver 19.8 (4.1)b 1.5 (0.3) 1.4 (0.5) 4.5 (1.1)
Kidney 27.4 (3.5)b 2.1 (0.4) 1.3 (0.2) 5.1 (3.1)
Lung 30.4 (2.8)b 2.3 (0.5) 3.0 (0.8) 11.2 (5.7)
a

Mean (± Standard Deviation), μg/mL

b

Mean (± Standard Deviation), μg/g